CORONA Remedies secures EU-GMP certification for hormone facility, renews approval for Ahmedabad OSD…
Approvals support CORONA Remedies’ hormone manufacturing capabilities and expansion plans across regulated and semi-regulated…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Corona Remedies
CORONA Remedies announces strategic acquisition of Wokadine in India
CORONA Remedies announced the acquisition of Wokadine from Dr. Reddy’s Laboratories, a global pharmaceutical company headquartered…
Industry calls Union Budget 2026 a defining moment for India’s biopharma future
Industry stakeholders view the Union Budget 2026 as a pivotal inflection point in India’s life sciences journey. With the launch…
Corona Remedies commences capacity expansion at Bhayla facility
Expansion increases tablet and capsule production capacity from December 22, 2025
CORONA Remedies acquires seven Bayer India brands to expand cardiology and women’s health portfolio
The acquisition marks CORONA Remedies' entry into the anti-platelet market and strengthens its position in India’s fertility and…
Corona Remedies pledges ₹25 cr towards CSR
As part of its 20th anniversary celebrations, the company donated to 20 NGOs across Gujarat and Maharashtra
CORONA, Ferring partner to commercialise maternal health, urology products in India
The estimated market size for the said products collectively is Rs 778.30 crores
Corona Remedies to invest Rs 20-25 cr for hormone facility
The company plans to launch two NCEs in hormonal range before March 2021
CORONA Remedies picks up stake in La Chandra Pharmalab
La Chandra Pharmalab is a manufacturer and supplier of pregnancy care drug progesterone and a range of hormone APIs
Is China the next land of opportunity?
As opportunities in developed markets saturate, India Pharma Inc is looking to optimise the growth potential in China. But what…